Cargando…
Survivin: A molecular biomarker in cancer
Survivin, a member of the inhibitor of apoptosis (IAP) protein family that inhibits caspases and blocks cell death, is highly expressed in most cancers and is associated with a poor clinical outcome. Survivin has consistently been identified by molecular profiling analysis to be associated with high...
Autores principales: | Jaiswal, Praveen Kumar, Goel, Apul, Mittal, R.D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4510718/ https://www.ncbi.nlm.nih.gov/pubmed/26112839 http://dx.doi.org/10.4103/0971-5916.159250 |
Ejemplares similares
-
Diseases and Molecular Diagnostics: A Step Closer to Precision Medicine
por: Dwivedi, Shailendra, et al.
Publicado: (2017) -
Survivin-T34A: molecular mechanism and therapeutic potential
por: Aspe, Jonathan R, et al.
Publicado: (2010) -
Survivin and Tumorigenesis: Molecular Mechanisms and Therapeutic Strategies
por: Chen, Xun, et al.
Publicado: (2016) -
Emerging Importance of Survivin in Stem Cells and Cancer: the Development of New Cancer Therapeutics
por: Warrier, Neerada Meenakshi, et al.
Publicado: (2020) -
Lower urinary tract symptoms and benign prostatic hyperplasia: From research to bedside
por: Goel, Apul
Publicado: (2019)